Experimental Studies on the Production of Pulmonary Infarction:Especially from Coagulative and Fibrinolytic Studies
スポンサーリンク
概要
- 論文の詳細を見る
In this experiment, attempts were made to clarify the mechanism with which the pulmonary infarction occurs, from coagulofibrinolytic point of view. The following results were obtained.1) Injection of the human serum (2ml./Kg.) into the rabbits provoked a hypercoagulative state within 2min. after the injection, followed by a decrease afterward with accelerated fibrinolytic activity. The control level was resumed about 1 hour after the injection.2) Changes in the coagulofibrinolytic system induced by lycopodium spores infusion progressed slowly toward a marked hypercoagulative state with reduced fibrinolytic activity seen 2 to 3 days later. Injection of the blood clots at this time yielded a high mortality among the animals.However the pulmonary infarction tended to occur in the survived.3) Although natural liquefaction of the blood clots, when injected at the 5th day after the lycopodium spores infusion, was seen in the majority of the cases, intravenous injection of t-AMCHA in combination with the procedure produced the pulmonary infarction in 62.5% of the animals, and further addition of intravenous injection of the human serum yielded the highest rate (88.9%) in producing the infarct.The tissue activator was a high activity in the infarcted area for 6 hours after the blood clot injection, but showed a decrease below control level after 3 to 5 days.4) The same procedure performed I month or later after the lycopodium infusion failed to produce the infarct.5) It is concluded from these observations that the following 3 factors, cessation of the blood flow in the collateral vessels brought by repeated microembolization as can be obtained experimentally by the lycopodium infusion, hypercoagulative state in the blood, and reduction of fibrinolytic activity, are sine qua non in producing the pulmonary infarction. Embolization of the pulmonary artery with large embolus or emboli, and injury in the capillary beds as might be brought about by a heterologous serum injection are additional factors in the occurrence of the infarcts.
- International Heart Journal刊行会の論文
著者
-
Hasegawa Hiroshi
First Department Of Surgery Nippon Medical School
-
KAKIZAKI Hironobu
First Department of Medicine, Hokkaido University School of Medicine
-
MURAO Makoto
First Department of Internal Medicine, Hokkaido University School of Medicine
-
WATANABE Nobuo
First Department of Medicine, Hokkaido University School of Medicine
-
WATANABE Naoyoshi
First Department of Medicine, Hokkaido University School of Medicine
-
KAKIZAKI Hironobu
First Department of Medicine, Hokkaido University, School of Medicine
-
KAWAI Terukuni
First Department of Medicine, Hokkaido University, School of Medicine
-
WATANABE Naoyoshi
First Department of Medicine, Hokkaido University, School of Medicine
-
MURAO Makoto
First Department of Medicine, Hokkaido University, School of Medicine
関連論文
- Pancreatic Enzyme Activity After a Pylorus-Preserving Pancreaticoduodenectomy Reconstructed with Pancreaticogastrostomy
- In situ Gene Transfer and Suicide Gene Therapy of Gastric Cancer Induced by N-Ethyl-N'-nitro-N-nitrosoguanidine in Dogs
- Cytotoxin Genes of Helicobacter pylori in Chronic Gastritis, Gastroduodenal Ulcer and Gastric Cancer: An Age and Gender Matched Case-Control Study
- A Prospective Randomized Trial of the Preventive Effect of Pre-operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma
- THE EFFECTS OF POSTURE ON CAPILLARY BLOOD FLOW PULSE AND GAS EXCHANGE IN THE LUNGS OF MAN
- Use of bromthymol blue, a pH indicator, for detecting the pancreatic duct orifice after resection of the head of the pancreats
- Complete duodenum-preserving resection of the head of the pancreas with preservation of the biliary tract
- Effects of Occlusion and Further Distension of Unilateral Pulmonary Artery with an Inflatable Balloon upon Systemic and Pulmonary Hemodynamics
- Role of Dextran Sulfate in Urokinase Therapy and Evaluation of the Effects by Estimation of Plasmin Inhibitor, Fibrinogenolytic Degradation Products, and Fibrinolytic Degradation Products
- Assay of Heparin in Plasma Using a Chromogenic Substrate and Its Clinical Applications
- Experimental Studies on the Production of Pulmonary Infarction (III):Especially from Coagulative and Fibrinolytic Studies
- Further Experimental Studies on the Production of Pulmonary Infarction:Especially from Coagulative and Fibrinolytic Studies
- Experimental Studies on the Production of Pulmonary Infarction:Especially from Coagulative and Fibrinolytic Studies
- Experimental Studies on the Production of Pulmonary Infarction (IV):Effects of UK, Heparin, t-AMCHA or Ellagic Acid
- Potential thrombolysis under selective infusion of autologous plasmin(AP) solution.